dRx Capital
21
27M
13
2.62
1
0.38
2
- Stages of investment
- Areas of investment
Summary
dRx Capital is the famous VC, which was founded in 2015. The main office of represented VC is situated in the San Diego. The company was established in North America in United States.
The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The average startup value when the investment from dRx Capital is 100-500 millions dollars. The important activity for fund was in 2016.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular fund investment industries, there are Information Technology, Neuroscience. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Omada Health, Cala Health, Science 37.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the dRx Capital, startups are often financed by Lux Capital, U.S. Venture Partners (USVP), TriplePoint Capital. The meaningful sponsors for the fund in investment in the same round are Lux Capital, GV, Sanofi-Genzyme BioVentures. In the next rounds fund is usually obtained by Sanofi-Genzyme BioVentures, Lux Capital, U.S. Venture Partners (USVP).
We also calculated 1 valuable employee in our database.
Investments analytics
Analytics
- Total investments
- 21
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 2.62
- Follow on index
- 0.38
- Investments by industry
- Health Care (16)
- Biotechnology (12)
- Medical (6)
- Pharmaceutical (6)
- Medical Device (5) Show 17 more
- Investments by region
-
- United States (18)
- United Kingdom (2)
- Germany (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 132M
- Group Appearance index
- 0.86
- Avg. company exit year
- 22
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Peptone | 09 Jun 2022 | Biotechnology, Artificial Intelligence, Pharmaceutical, Quantum Computing | Early Stage Venture | 40M | England, London, United Kingdom |
| SomaLogic | 01 Jan 2014 | Biotechnology, Health Care, Health Diagnostics, Medical Device, Life Science, Pharmaceutical | Early Stage Venture | United States, Boulder, Colorado |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.